Top Point-of-care Glucose Testing Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Point-of-care Glucose Testing Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Point-of-care Glucose Testing industry players.

Point-of-care Glucose Testing Market Competitive Landscape

The global point-of-care glucose testing market is a highly competitive landscape with the presence of several key players. These companies strive to maintain their market position by focusing on product innovation, strategic partnerships, and geographical expansion. Key players in the competitive landscape of the global point-of-care glucose testing market continuously strive to introduce advanced technologies, improve product efficacy, and enhance user experience. They also engage in strategic partnerships, mergers, and acquisitions to strengthen their market position and expand their geographical presence. With a focus on innovation and customer-centric approaches, these companies contribute significantly to the growth and development of the point-of-care glucose testing market.

Top Players in Point-of-care Glucose Testing Market

  • Abbott Laboratories (USA) 
  • Roche Holding AG (Switzerland) 
  • Ascensia Diabetes Care Holdings AG (Switzerland) 
  • Dexcom, Inc. (USA) 
  • Medtronic plc (Ireland) 
  • LifeScan, Inc. (USA) 
  • Becton, Dickinson and Company (BD) (USA) 
  • ACON Laboratories, Inc. (USA) 
  • Nova Biomedical Corporation (USA) 
  • ARKRAY, Inc. (Japan) 
  • Trividia Health, Inc. (USA) 
  • PTS Diagnostics (USA) 
  • Nipro Corporation (Japan) 
  • Ypsomed Holding AG (Switzerland) 
  • Sanofi S.A. (France) 
  • EKF Diagnostics Holdings plc (UK) 
  • Prodigy Diabetes Care, LLC (USA) 
  • Bayer AG (Germany) 
  • Danaher Corporation (USA) 
  • Platinum Equity Advisors, LLC (USA)

Point-of-care Glucose Testing Market

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Point-of-care Glucose Testing Market size was valued at USD 3.44 Billion in 2023 and is poised to grow from USD 3.58 Billion in 2024 to USD 4.98 Billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global point-of-care glucose testing market is a highly competitive landscape with the presence of several key players. These companies strive to maintain their market position by focusing on product innovation, strategic partnerships, and geographical expansion. Key players in the competitive landscape of the global point-of-care glucose testing market continuously strive to introduce advanced technologies, improve product efficacy, and enhance user experience. They also engage in strategic partnerships, mergers, and acquisitions to strengthen their market position and expand their geographical presence. With a focus on innovation and customer-centric approaches, these companies contribute significantly to the growth and development of the point-of-care glucose testing market. 'Abbott Laboratories (USA) ', 'Roche Holding AG (Switzerland) ', 'Ascensia Diabetes Care Holdings AG (Switzerland) ', 'Dexcom, Inc. (USA) ', 'Medtronic plc (Ireland) ', 'LifeScan, Inc. (USA) ', 'Becton, Dickinson and Company (BD) (USA) ', 'ACON Laboratories, Inc. (USA) ', 'Nova Biomedical Corporation (USA) ', 'ARKRAY, Inc. (Japan) ', 'Trividia Health, Inc. (USA) ', 'PTS Diagnostics (USA) ', 'Nipro Corporation (Japan) ', 'Ypsomed Holding AG (Switzerland) ', 'Sanofi S.A. (France) ', 'EKF Diagnostics Holdings plc (UK) ', 'Prodigy Diabetes Care, LLC (USA) ', 'Bayer AG (Germany) ', 'Danaher Corporation (USA) ', 'Platinum Equity Advisors, LLC (USA)'

The increasing global incidence of diabetes is a major driver of the point-of-care glucose testing market. According to the International Diabetes Federation, the number of adults living with diabetes is expected to reach 700 million by 2045. This surge in diabetes cases necessitates regular glucose monitoring, leading to a higher demand for point-of-care testing devices.

Integration with Digital Health Platforms: The integration of point-of-care glucose testing devices with digital health platforms and electronic health records is a significant trend in 2022. This integration enables seamless data transfer, analysis, and real-time monitoring of glucose levels. It empowers patients to actively participate in their diabetes management and allows healthcare professionals to make informed treatment decisions based on comprehensive patient data.

North America holds the largest market share in the global point-of-care glucose testing market. This dominance can be attributed to several factors, including the high prevalence of diabetes in the region, well-established healthcare infrastructure, and favorable reimbursement policies. The presence of key market players, technological advancements, and the adoption of innovative glucose testing devices contribute to the region's leadership position. Additionally, increasing awareness among healthcare professionals and patients about the benefits of point-of-care glucose testing drives market growth in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Glucose Tolerance Test Market
Buy Now GET FREE SAMPLE
Blood Glucose Monitoring Devices Market
Buy Now GET FREE SAMPLE
Continuous Glucose Monitoring Devices Market
Buy Now GET FREE SAMPLE
Blood Glucose Test Strips Market
Buy Now GET FREE SAMPLE
Point Of Care Diagnostics Market
Buy Now GET FREE SAMPLE
Diabetes Care Devices Market
Buy Now GET FREE SAMPLE
Diabetes Device Market
Buy Now GET FREE SAMPLE
Diabetes Care Devices and Drugs Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Point-of-care Glucose Testing Market
Point-of-care Glucose Testing Market

Report ID: SQMIG15E2398

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE